Literature DB >> 27543611

Inclusion of Epitopes That Expand High-Avidity CD4+ T Cells Transforms Subprotective Vaccines to Efficacious Immunogens against Virulent Francisella tularensis.

Lydia M Roberts1, Deborah D Crane1, Tara D Wehrly1, Joshua R Fletcher2, Bradley D Jones2, Catharine M Bosio3.   

Abstract

T cells are the immunological cornerstone in host defense against infections by intracellular bacterial pathogens, such as virulent Francisella tularensis spp. tularensis (Ftt). The general paucity of novel vaccines for Ftt during the past 60 y can, in part, be attributed to the poor understanding of immune parameters required to survive infection. Thus, we developed a strategy utilizing classical immunological tools to elucidate requirements for effective adaptive immune responses directed against Ftt. Following generation of various Francisella strains expressing well-characterized lymphocytic choriomeningitis virus epitopes, we found that survival correlated with persistence of Ag-specific CD4(+) T cells. Function of these cells was confirmed in their ability to more effectively control Ftt replication in vitro. The importance of understanding the Ag-specific response was underscored by our observation that inclusion of an epitope that elicits high-avidity CD4(+) T cells converted a poorly protective vaccine to one that engenders 100% protection. Taken together, these data suggest that improved efficacy of current tularemia vaccine platforms will require targeting appropriate Ag-specific CD4(+) T cell responses and that elucidation of Francisella epitopes that elicit high-avidity CD4(+) T cell responses, specifically in humans, will be required for successful vaccine development.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27543611      PMCID: PMC5026927          DOI: 10.4049/jimmunol.1600879

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Cutting edge: virus-specific CD4+ memory T cells in nonlymphoid tissues express a highly activated phenotype.

Authors:  Linda S Cauley; Tres Cookenham; Timothy B Miller; Pamela S Adams; Kate M Vignali; Dario A A Vignali; David L Woodland
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

2.  Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage.

Authors:  Raymond M Welsh; Mina O Seedhom
Journal:  Curr Protoc Microbiol       Date:  2008-02

3.  Loss of either CD4+ or CD8+ T cells does not affect the magnitude of protective immunity to an intracellular pathogen, Francisella tularensis strain LVS.

Authors:  D Yee; T R Rhinehart-Jones; K L Elkins
Journal:  J Immunol       Date:  1996-12-01       Impact factor: 5.422

4.  Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.

Authors:  Rebecca V Anderson; Deborah D Crane; Catharine M Bosio
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

5.  Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.

Authors:  Amanda J Griffin; Deborah D Crane; Tara D Wehrly; Catharine M Bosio
Journal:  Clin Vaccine Immunol       Date:  2014-11-19

Review 6.  Tularemia vaccines: recent developments and remaining hurdles.

Authors:  J Wayne Conlan
Journal:  Future Microbiol       Date:  2011-04       Impact factor: 3.165

7.  Aerosol-, but not intradermal-immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an alphabeta T cell- and interferon gamma- dependent mechanism.

Authors:  J Wayne Conlan; Hua Shen; Rhonda Kuolee; Xigeng Zhao; Wangxue Chen
Journal:  Vaccine       Date:  2005-03-31       Impact factor: 3.641

8.  Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system.

Authors:  A Oxenius; M F Bachmann; P G Ashton-Rickardt; S Tonegawa; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  1995-12       Impact factor: 5.532

9.  IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.

Authors:  Lydia M Roberts; John S Davies; Gregory D Sempowski; Jeffrey A Frelinger
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

10.  Generation of a convalescent model of virulent Francisella tularensis infection for assessment of host requirements for survival of tularemia.

Authors:  Deborah D Crane; Dana P Scott; Catharine M Bosio
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

View more
  10 in total

1.  Temporal Requirement for Pulmonary Resident and Circulating T Cells during Virulent Francisella tularensis Infection.

Authors:  Lydia M Roberts; Tara D Wehrly; Robin M Ireland; Deborah D Crane; Dana P Scott; Catharine M Bosio
Journal:  J Immunol       Date:  2018-07-06       Impact factor: 5.422

2.  Circulating T Cells Are Not Sufficient for Protective Immunity against Virulent Francisella tularensis.

Authors:  Lydia M Roberts; Tara D Wehrly; Ian Leighton; Patrick Hanley; Jamie Lovaglio; Brian J Smith; Catharine M Bosio
Journal:  J Immunol       Date:  2022-02-11       Impact factor: 5.422

3.  Contribution of Lipid Mediators in Divergent Outcomes following Acute Bacterial and Viral Lung Infections in the Obese Host.

Authors:  Benjamin Schwarz; Lydia M Roberts; Eric Bohrnsen; Forrest Jessop; Tara D Wehrly; Carl Shaia; Catharine M Bosio
Journal:  J Immunol       Date:  2022-08-24       Impact factor: 5.426

4.  Development of a novel Francisella tularensis Live Vaccine Strain expressing ovalbumin provides insight into antigen-specific CD8+ T cell responses.

Authors:  David E Place; David R Williamson; Yevgeniy Yuzefpolskiy; Bhuvana Katkere; Surojit Sarkar; Vandana Kalia; Girish S Kirimanjeswara
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

5.  Differential Growth of Francisella tularensis, Which Alters Expression of Virulence Factors, Dominant Antigens, and Surface-Carbohydrate Synthases, Governs the Apparent Virulence of Ft SchuS4 to Immunized Animals.

Authors:  Kristen M Holland; Sarah J Rosa; Kolbrun Kristjansdottir; Donald Wolfgeher; Brian J Franz; Tiffany M Zarrella; Sudeep Kumar; Raju Sunagar; Anju Singh; Chandra S Bakshi; Prachi Namjoshi; Eileen M Barry; Timothy J Sellati; Stephen J Kron; Edmund J Gosselin; Douglas S Reed; Karsten R O Hazlett
Journal:  Front Microbiol       Date:  2017-06-22       Impact factor: 5.640

Review 6.  Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

Authors:  Lydia M Roberts; Daniel A Powell; Jeffrey A Frelinger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-06       Impact factor: 5.293

7.  Evaluation of an outbred mouse model for Francisella tularensis vaccine development and testing.

Authors:  Raju Sunagar; Sudeep Kumar; Prachi Namjoshi; Sarah J Rosa; Karsten R O Hazlett; Edmund J Gosselin
Journal:  PLoS One       Date:  2018-12-11       Impact factor: 3.240

8.  Systems Vaccinology for a Live Attenuated Tularemia Vaccine Reveals Unique Transcriptional Signatures That Predict Humoral and Cellular Immune Responses.

Authors:  Muktha S Natrajan; Nadine Rouphael; Lilin Lai; Dmitri Kazmin; Travis L Jensen; David S Weiss; Chris Ibegbu; Marcelo B Sztein; William F Hooper; Heather Hill; Evan J Anderson; Robert Johnson; Patrick Sanz; Bali Pulendran; Johannes B Goll; Mark J Mulligan
Journal:  Vaccines (Basel)       Date:  2019-12-24

9.  Working correlates of protection predict SchuS4-derived-vaccine candidates with improved efficacy against an intracellular bacterium, Francisella tularensis.

Authors:  Roberto De Pascalis; Blake Frey; Helen M Rice; Varunika Bhargava; Terry H Wu; Ross L Peterson; J Wayne Conlan; Anders Sjöstedt; Karen L Elkins
Journal:  NPJ Vaccines       Date:  2022-08-17       Impact factor: 9.399

10.  Protection induced by a Francisella tularensis subunit vaccine delivered by glucan particles.

Authors:  Adam O Whelan; Helen C Flick-Smith; Jane Homan; Zu T Shen; Zoe Carpenter; Payam Khoshkenar; Ambily Abraham; Nicola J Walker; Stuart M Levitz; Gary R Ostroff; Petra C F Oyston
Journal:  PLoS One       Date:  2018-10-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.